Scottsdale, AZNCT06464926Now EnrollingIRB Ready

Nausea Clinical Trial in Scottsdale, AZ

Access cutting-edge nausea treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.

Sponsored by Enterra Medical, Inc.

Quick Self-Assessment

See if you qualify for this Scottsdale location

Preparing your pre-screening questions…

Expert Care in Scottsdale

Access nausea specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related nausea treatment provided free

Apply for This Scottsdale Location

Check if you qualify for this nausea clinical trial in Scottsdale, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Scottsdale

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Scottsdale site if eligible
  4. 4Begin participation

About This Nausea Study in Scottsdale

The purpose of this research study is to determine if the Enterra® Therapy System can decrease nausea and vomiting symptoms and improve the quality of life for patients with chronic nausea, with or without vomiting, that have normal gastric emptying.

Sponsor: Enterra Medical, Inc.

Who Can Participate

Inclusion Criteria

Willing and able to complete the informed consent process
Stated willingness to comply with all study procedures and availability for the duration of the study
Aged ≥18 years at time of informed consent
Chronic, drug-refractory nausea that: a) has been present for more than 6 months, and b) has been active within the last 3 months prior to consent
Patient is able to complete ANMS GCSI-DD surveys on a compatible smart device with: a) a minimum of four (4) ANMS GCSI-DD entries per week for two consecutive weeks, and b) an average ANMS GCSI-DD score for nausea severity of ≥2.5 during the same two-week period
Refractory or intolerant to two or more of the following antiemetic drug classes: antihistamines, phenothiazines, serotonin type 3 receptor antagonists, dopamine type 2 receptor antagonists, anticholinergics, neurokinin receptor antagonists
Medically stable, in the opinion of the investigator, during the month prior to consent, with no planned modifications to medical therapy during the course of the study
Normal gastric emptying as assessed by a qualifying gastric emptying test performed within 2 years of consent if no prior pyloric transection therapy, or within 2 years of consent and after the most recent pyloric transection therapy
Normal upper endoscopy within 1 year prior to consent (e.g., absence of obstructions, ulcers, or cancers in the esophagus, stomach, or duodenum) performed within 1 year of consent if no prior pyloric transection therapy, or within 1 year of consent and after the most recent pyloric transection therapy

Exclusion Criteria

Cognitive impairment or other characteristic that would limit a patient's ability to complete study requirements
Pyloric transection therapy completed within 1 year of consent
Documented gastrointestinal (GI) obstruction or pseudo-obstruction
History of primary swallowing disorders
History of primary psychogenic vomiting
History of primary eating disorder
History of cyclic vomiting syndrome
History of rumination syndrome
History of scleroderma
History of amyloidosis
History of cannabis hyperemesis syndrome
Active H. pylori infection
Evidence of bezoar during most recent endoscopy
Previous gastric surgery of any type other than a pyloric transection therapy (i.e., pyloroplasty, pyloromyotomy, POP, or G-POEM)
Uncontrolled thyroid disorder, in the opinion of the investigator
History of seizures disorders
Hemoglobin A1c \>8.0%
Peritoneal dialysis or unstable hemodialysis
Parenteral or enteral nutritional support
Active pancreatitis
History of organ transplant, gross malabsorptive syndromes, celiac disease, or inflammatory bowel disease
Other GI tract diseases and disorders that the investigator believes may have caused the patient's drug-refractory nausea and/or vomiting
Malignancy (with the exception of basal cell carcinoma of the skin) currently present, initially diagnosed or recurring within 5 years of consent
Current cannabis/cannabinoid use that exceeds: 3 days of usage per week, or 2 occurrences during each day of use, or 3 grams of total usage per week
Heavy alcohol use, defined as: for men, consuming five or more drinks on any day or 15 or more per week; for women, consuming four or more drinks on any day or 8 or more per week
Injection of Botox into the pyloric sphincter within 6 months of consent
Active major levels of anxiety/depression, as determined by the investigator
History of other clinically significant disease, or any other condition which, in the opinion of the Investigator, would jeopardize the safety of the patient or impact the validity of the study results
Life expectancy \<1 year
Pregnant or breastfeeding at the time of consent or intend to become pregnant during the study
Any underlying disease leading to follow-up by MRI outside of current MR conditional indications
Glucagon-like peptide 1 (GLP-1) agonist drug use within 6 months of consent
Participation in other investigational clinical studies
Existing or prior gastric electrical stimulator implantation

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Scottsdale?

Yes, this clinical trial (NCT06464926) has an active research site in Scottsdale, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Nausea Treatment Options in Scottsdale, AZ

If you're searching for nausea treatment options in Scottsdale, AZ, this clinical trial (NCT06464926) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nausea specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Scottsdale?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Scottsdale, AZ